DE602004024037D1 - Substituierte heterozyklen - Google Patents
Substituierte heterozyklenInfo
- Publication number
- DE602004024037D1 DE602004024037D1 DE602004024037T DE602004024037T DE602004024037D1 DE 602004024037 D1 DE602004024037 D1 DE 602004024037D1 DE 602004024037 T DE602004024037 T DE 602004024037T DE 602004024037 T DE602004024037 T DE 602004024037T DE 602004024037 D1 DE602004024037 D1 DE 602004024037D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted heterocycles
- heterocycles
- substituted
- medicaments
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03003495 | 2003-02-14 | ||
EP03007594 | 2003-04-02 | ||
PCT/EP2004/001097 WO2004071382A2 (en) | 2003-02-14 | 2004-02-06 | Substituted heterocycles |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004024037D1 true DE602004024037D1 (de) | 2009-12-24 |
Family
ID=32870763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004024037T Expired - Lifetime DE602004024037D1 (de) | 2003-02-14 | 2004-02-06 | Substituierte heterozyklen |
Country Status (16)
Country | Link |
---|---|
US (2) | US20060229353A1 (de) |
EP (1) | EP1597262B1 (de) |
JP (1) | JP4795931B2 (de) |
KR (1) | KR20050098928A (de) |
CN (1) | CN1845925B (de) |
AT (1) | ATE448232T1 (de) |
AU (1) | AU2004212296B2 (de) |
BR (1) | BRPI0407234A (de) |
CA (1) | CA2515940C (de) |
DE (1) | DE602004024037D1 (de) |
ES (1) | ES2336562T3 (de) |
HK (1) | HK1096392A1 (de) |
IL (1) | IL169897A0 (de) |
IN (1) | IN228043B (de) |
MX (1) | MX272108B (de) |
WO (1) | WO2004071382A2 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002243228B2 (en) | 2000-11-16 | 2007-08-02 | The Regents Of The University Of California | Marine actinomycete taxon for drug and fermentation product discovery |
US7176232B2 (en) | 2002-06-24 | 2007-02-13 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
PL2441767T3 (pl) | 2003-06-20 | 2015-11-30 | Univ California | Salinosporamidy i sposoby ich stosowania |
AU2004253478A1 (en) * | 2003-06-20 | 2005-01-13 | Nereus Pharmaceuticals, Inc. | Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
WO2005099687A2 (en) * | 2004-04-09 | 2005-10-27 | President And Fellows Of Harvard College | Analogs of salinosporamide a |
US7579371B2 (en) | 2004-04-30 | 2009-08-25 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
MXPA06012421A (es) * | 2004-04-30 | 2007-01-31 | Nereus Pharmaceuticals Inc | Compuestos de heterociclicos y metodos para utilizar los mismos. |
JP2008505956A (ja) * | 2004-07-12 | 2008-02-28 | バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト | 真菌駆除剤および昆虫駆除剤としての置換されている2−ピロリドン誘導体 |
KR101282191B1 (ko) * | 2004-12-03 | 2013-07-08 | 다나-파버 캔서 인스티튜트 인크. | 신생물성 질환을 치료하는 조성물 및 방법 |
CA2590334A1 (en) * | 2004-12-03 | 2006-06-08 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
WO2006118973A2 (en) * | 2005-04-29 | 2006-11-09 | Nereus Pharmaceuticals, Inc. | Methods of using heterobyclic compounds for treatment of rectal cancer |
US7465720B2 (en) | 2005-09-12 | 2008-12-16 | President And Fellows Of Harvard College | Proteasome inhibiting β-lactam compounds |
CA2648317A1 (en) | 2006-04-06 | 2007-10-18 | Nereus Pharmaceuticals, Inc. | Total synthesis of salinosporamide a and analogs thereof |
WO2008095195A2 (en) | 2007-02-02 | 2008-08-07 | Nereus Pharmaceuticals, Inc. | Lyophilized formulations of salinosporamide a |
US20080280968A1 (en) * | 2007-05-04 | 2008-11-13 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
US8394816B2 (en) * | 2007-12-07 | 2013-03-12 | Irene Ghobrial | Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia |
EP2088205A1 (de) | 2008-02-11 | 2009-08-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | PSMB10: Diagnosemarker und therapeutisches Target für chronische Abstoßung |
KR20100131475A (ko) | 2008-03-07 | 2010-12-15 | 니리어스 파마슈티컬즈, 인코퍼레이션 | 살리노스포라마이드 a 및 그의 유사체들의 전합성 |
MX2010012341A (es) | 2008-05-12 | 2010-12-06 | Nereus Pharmaceuticals Inc | Derivados de salinosporamida como inhibidores de proteasoma. |
EP3021120A1 (de) | 2009-02-20 | 2016-05-18 | Michael P. Lisanti | Verfahren zur diagnose oder prognose eines neoplasmas einschliesslich der bestimmung des expressionsgrads eines proteins in stromazellen neben dem neoplasma |
US9126997B1 (en) | 2010-09-07 | 2015-09-08 | Northwestern University | Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma |
ES2776144T3 (es) | 2011-10-28 | 2020-07-29 | Millennium Pharm Inc | Biomarcadores de respuesta a inhibidores de NAE |
CA2855368A1 (en) | 2011-11-11 | 2013-05-16 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to proteasome inhibitors |
WO2013112601A1 (en) | 2012-01-24 | 2013-08-01 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
WO2013112881A1 (en) | 2012-01-27 | 2013-08-01 | Thomas Jefferson University | Mct protein inhibitor-related prognostic and therapeutic methods |
JP6486826B2 (ja) | 2012-10-01 | 2019-03-20 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 阻害剤に対する応答を予測するためのバイオマーカーおよび方法、ならびにそれらの使用 |
EP2986290A4 (de) | 2013-04-19 | 2017-01-04 | Thomas Jefferson University | Caveolin-1-verwandte verfahren zur behandlung von glioblastom mit temozolomid |
EP3339291A1 (de) | 2016-12-22 | 2018-06-27 | Vita Api | Proteasomhemmende ss-lactam-prodrugs, die zur behandlung von krebs und neurodegenerativen erkrankungen nützlich sind |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6335358B1 (en) * | 1995-04-12 | 2002-01-01 | President And Fellows Of Harvard College | Lactacystin analogs |
AU2002243228B2 (en) * | 2000-11-16 | 2007-08-02 | The Regents Of The University Of California | Marine actinomycete taxon for drug and fermentation product discovery |
-
2004
- 2004-02-06 WO PCT/EP2004/001097 patent/WO2004071382A2/en active Application Filing
- 2004-02-06 AT AT04708731T patent/ATE448232T1/de not_active IP Right Cessation
- 2004-02-06 CA CA2515940A patent/CA2515940C/en not_active Expired - Fee Related
- 2004-02-06 US US10/545,449 patent/US20060229353A1/en not_active Abandoned
- 2004-02-06 CN CN2004800093759A patent/CN1845925B/zh not_active Expired - Fee Related
- 2004-02-06 BR BR0407234-0A patent/BRPI0407234A/pt not_active IP Right Cessation
- 2004-02-06 AU AU2004212296A patent/AU2004212296B2/en not_active Ceased
- 2004-02-06 DE DE602004024037T patent/DE602004024037D1/de not_active Expired - Lifetime
- 2004-02-06 MX MXPA05008478 patent/MX272108B/es active IP Right Grant
- 2004-02-06 KR KR1020057014935A patent/KR20050098928A/ko active IP Right Grant
- 2004-02-06 JP JP2006501755A patent/JP4795931B2/ja not_active Expired - Fee Related
- 2004-02-06 IN IN3350DE2005 patent/IN228043B/en unknown
- 2004-02-06 EP EP04708731A patent/EP1597262B1/de not_active Expired - Lifetime
- 2004-02-06 ES ES04708731T patent/ES2336562T3/es not_active Expired - Lifetime
-
2005
- 2005-07-26 IL IL169897A patent/IL169897A0/en unknown
-
2007
- 2007-03-30 HK HK07103474.2A patent/HK1096392A1/xx not_active IP Right Cessation
-
2009
- 2009-01-08 US US12/350,696 patent/US20110015248A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060229353A1 (en) | 2006-10-12 |
EP1597262B1 (de) | 2009-11-11 |
WO2004071382A3 (en) | 2005-01-06 |
JP4795931B2 (ja) | 2011-10-19 |
KR20050098928A (ko) | 2005-10-12 |
CA2515940A1 (en) | 2004-08-26 |
IN2005DE03350A (de) | 2007-06-01 |
CN1845925B (zh) | 2010-11-03 |
IN228043B (de) | 2009-02-13 |
ATE448232T1 (de) | 2009-11-15 |
MXPA05008478A (es) | 2005-10-18 |
JP2006517934A (ja) | 2006-08-03 |
EP1597262A2 (de) | 2005-11-23 |
HK1096392A1 (en) | 2007-06-01 |
CA2515940C (en) | 2011-12-06 |
US20110015248A1 (en) | 2011-01-20 |
WO2004071382A2 (en) | 2004-08-26 |
BRPI0407234A (pt) | 2006-01-31 |
AU2004212296B2 (en) | 2010-06-17 |
IL169897A0 (en) | 2007-07-04 |
MX272108B (es) | 2009-11-25 |
AU2004212296A1 (en) | 2004-08-26 |
ES2336562T3 (es) | 2010-04-14 |
CN1845925A (zh) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE448232T1 (de) | Substituierte heterozyklen | |
UA85559C2 (en) | Aminobenzophenone compounds | |
NO20073574L (no) | Triazolsubstituerte aminobenzofenonforbindelser | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
DE50310516D1 (de) | Fredericamycin-derivate | |
CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
IL209879A0 (en) | Substituted pteridines ,pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating inflammatory diseases | |
CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
SE0302304D0 (sv) | Novel compounds | |
ATE475651T1 (de) | Aryl-substituierte heterozyklen und ihre verwendung | |
ATE524488T1 (de) | Lysobactinamide | |
SE0300457D0 (sv) | Novel compounds | |
ATE380188T1 (de) | Substituierte chinolone | |
ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
ATE455789T1 (de) | Substituierte nonadepsipeptide | |
DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
DE502005005652D1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
SV2003001061A (es) | Nuevos heterociclos 3 ref.lea 35361-sv | |
ATE553088T1 (de) | Substituierte chinolone ii | |
ATE481392T1 (de) | Benzimidazolderivate zur behandlung entzündlicher erkrankungen | |
ATE435868T1 (de) | Homogemcitabine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |